Bo and I discuss some of the leading candidates for extending both human lifespan and “health-span”, including metformin, nicotinamide riboside & nicotinamide mononucleotide, and caloric restriction. We also chat about some of the companies working in this area, as well as novel business models that may or may not be a strategy to enable rigorous research of something as difficult to study as human lifespan.

Episode ID: 1000437646975

GUID: 568c08e50ab377164e9ca233:5694f372a2bab8c9489fb1a7:5cd443f97817f750f0013abd

Release Date: 09/05/2019, 22:12:27